kerendia
bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - agenti che agiscono sul sistema renina-angiotensina - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.
qaialdo
nova laboratories ireland limited - spironolattone - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 e 5.
aqumeldi
proveca pharma limited - enalapril (maleate) - insufficienza cardiaca - agenti che agiscono sul sistema renina-angiotensina - treatment of heart failure.
valprex
a.g.i.p.s. farmaceutici srl - valsartan - valsartan
enalapril eg
eg s.p.a. - enalapril - enalapril
benazepril aurobindo
aurobindo pharma (italia) s.r.l. - benazepril - benazepril
valsodiur
i.b.n. savio s.r.l - valsartan e diuretici - valsartan e diuretici
ivabradina aristo pharma
aristo pharma gmbh - ivabradina - ivabradina
giantrix
menarini international operations luxembourg s.a. - olmesartan medoxomil, amlodipine and hydrochlorothiazide - olmesartan medoxomil, amlodipine and hydrochlorothiazide
nistik
menarini international operations luxembourg s.a. - olmesartan medoxomil, amlodipine and hydrochlorothiazide - olmesartan medoxomil, amlodipine and hydrochlorothiazide